Nektar Therapeutics Other Long Term Liabilities (Quarterly) Insights

Nektar Therapeutics (NKTR)

72.09 -1.64 (-2.22%) USD | NASDAQ | Feb 23, 12:04

View Other Long Term Liabilities (Quarterly) for NKTR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Rigel Pharmaceuticals, Inc.	--
Insmed, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Ironwood Pharmaceuticals, Inc.	Upgrade
Lyell Immunopharma, Inc.	Upgrade